Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label a cathepsin K/cat-K inhibitor. Show all posts
Showing posts with label a cathepsin K/cat-K inhibitor. Show all posts
Tuesday, September 18, 2012

Merck's Phase III trial assessing fracture risk reduction with odanacatib..

›
Merck announced   an update on the Phase III trial assessing fracture risk reduction with odanacatib, (a cathepsin K/cat-K inhibitor see s...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.